CDC - Bring Your Brave - Health Care Provider Educational Resource

CDC - Bring Your Brave - Health Care Provider Educational Resource

This continuing education activity provides guidance and tools for health care providers on early-onset breast and ovarian cancer. Clinicians will learn about factors that increase risk for these cancers, ways to communicate more effectively with women at higher risk, and tools for assessing women’s risk of getting these cancers.

CME ACTIVITY—Clinical Anthology: Educating Medical Providers About Breast Cancer in Young Women

Medscape, LLC is pleased to provide online continuing medical education (CME), allowing clinicians and nurses the opportunity to earn CME credit.

This activity has been planned and implemented in accordance with the Accreditation Council for Continuing Medical Education and the American Nurses Credentialing Center (ANCC) through the joint providership of Medscape, LLC and CDC’s Division of Cancer Prevention and Control. Medscape, LLC is accredited by the ACCME to provide continuing medical education for physicians and by the ANCC to provide continuing medical education for nurses.

Medscape, LLC designates this interview-based CME activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™ and 1.5 ANCC Contact HourInstructional Design and Rational Credit. Physicians and nurses should claim only the credit commensurate with the extent of their participation in the activity.

To participate in this interview-based CME activity: (1) Review the learning objectives and author disclosures; (2) Study the education content; (3) Take the post-test with a 75% minimum passing score and complete the evaluation; (4) View and print certificate.

Release date: January 18, 2017.

Expiration date: January 18, 2018.

Learning Objectives

Upon completion of this activity, participants will have demonstrated increased knowledge regarding—

• Factors that place women at increased risk for early-onset breast and ovarian cancer.
• Strategies to improve communication with younger women at increased risk for breast and ovarian cancer.
• Clinically validated tools for assessing risk for breast cancer.

Faculty

Suzanne M. Mahon, RN, DNSc, AOCN, APNG; Adjunct Professor, Internal Medicine and the School of Nursing, Saint Louis University, St. Louis, Missouri. Disclosure: Suzanne M. Mahon, RN, DNSc, AOCN, APNG, has disclosed no relevant financial relationships.

Carolyn D. Runowicz, MD; Professor, Department of Obstetrics and Gynecology; Executive Associate Dean for Academic Affairs, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida. Disclosure: Carolyn D. Runowicz, MD, has disclosed no relevant financial relationships.

Jeffrey A. Tice, MD; Associate Professor of Medicine, University of California San Francisco, San Francisco, California. Disclosure: Jeffrey A. Tice, MD, has disclosed no relevant financial relationships.

Scientific Director and Writer

Susan L. Smith, MN, PhD; Lead Scientific Director, Medscape, LLC. Disclosure: Susan L. Smith, MN, PhD, has disclosed no relevant financial relationships.

Nicole Glennon, PhD; Freelance Medical Writer, Medscape, LLC. Disclosure: Nicole Glennon, PhD, has disclosed no relevant financial relationships.

CME Reviewer and Nurse Planner

Amy Bernard, MS, BSN, RN-BC; Lead Nurse Planner, Medscape, LLC. Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.